The Patent Finder
AP

Altathera Pharmaceuticals LLC

First filing 2018
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Nine patents currently held, every record listed here

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Aug 2038. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Aug 2038
Next term end
1
Patent families

When these terms end

Each bar runs from grant to computed term end. 2019 to 2043.
US 10,512,620 Method of Initiating and Escalating Sotalol Hydrochloride Dosing Aug 14, 2038
US 11,696,902 Method of Initiating and Escalating Sotalol Hydrochloride Dosing Aug 14, 2038
US 12,390,431 Method of Escalating Sotalol Hydrochloride Dosing Aug 14, 2038
US 11,344,518 Method of Converting Atrial Fibrillation to Normal Sinus Rhythm and Loading Oral Sotalol in a Shortened Time Frame Aug 14, 2038
US 12,403,109 Sotalol Hydrochloride Dosing Aug 14, 2038
US 12,740,947 Method of Initiating Sotalol Hydrochloride Dosing Aug 14, 2038
US 11,610,660 Antiarrhythmic Drug Dosing Methods, Medical Devices, and Systems Dec 31, 2041
US 12,396,970 Anti-Arrhythmic Compositions and Methods Feb 4, 2043
US 12,763,186 Antiarrhythmic Drug Dosing Methods and Systems and Prescription Drug Use Related Software Jul 4, 2043
20242029203420392043
18 pending applications: term is not computable until grant.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 11, 2027
    The maintenance fee for Method of Initiating and Escalating Sotalol Hydrochloride Dosing (US 11,696,902) comes due Jan 11, 2027. Unpaid by Jul 12, 2027, it lapses early.
  • 1 fee due Jun 24, 2027
    The maintenance fee for Method of Initiating and Escalating Sotalol Hydrochloride Dosing (US 10,512,620) comes due Jun 24, 2027. Unpaid by Dec 27, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 9 of 9

PatentTitleStatusExpiresConfidence
US 10,512,620Method of Initiating and Escalating Sotalol Hydrochloride Dosing
In force
 · High confidence
In forceHigh confidence
US 11,344,518Method of Converting Atrial Fibrillation to Normal Sinus Rhythm and Loading Oral Sotalol in a Shortened Time Frame
In force
 · High confidence
In forceHigh confidence
US 11,696,902Method of Initiating and Escalating Sotalol Hydrochloride Dosing
In force
 · High confidence
In forceHigh confidence
US 12,390,431Method of Escalating Sotalol Hydrochloride Dosing
In force
 · High confidence
In forceHigh confidence
US 12,403,109Sotalol Hydrochloride Dosing
In force
 · High confidence
In forceHigh confidence
US 12,740,947Method of Initiating Sotalol Hydrochloride Dosing
In force
 · High confidence
In forceHigh confidence
US 11,610,660Antiarrhythmic Drug Dosing Methods, Medical Devices, and Systems
In force
 · High confidence
In forceHigh confidence
US 12,396,970Anti-Arrhythmic Compositions and Methods
In force
 · High confidence
In forceHigh confidence
US 12,763,186Antiarrhythmic Drug Dosing Methods and Systems and Prescription Drug Use Related Software
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 9: 18 applications pending · 5 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited